GLP-1 Medications May Improve Health in People With PAD and Diabetes

Дата публикации: 18-08-2026 00:00:00

Glucagon-like peptide-1 (GLP-1) receptor agonists may reduce hospitalizations, amputations, and deaths among people with peripheral artery disease (PAD) and type 2 diabetes compared with metformin, a new study suggests.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	GLP-1s may improve outcomes in patients with PAD, diabetes	5	7	08-07-2026
2	Weight loss drugs may literally be saving people's arms and legs	5	7	06-07-2026
3	New GLP-1 diabetes pill delivers major weight loss and blood sugar control	0	6.91	15-06-2026
4	Popular GLP-1 weight-loss drugs like Ozempic slash heart attack and stroke risk	0	9.67	21-05-2026
5	GLP-1 Agonists May Help People With Diabetes and Long COVID	0	10.36	09-07-2026
6	GLP-1s for diabetes may increase risk for psoriatic disease	0	8.45	28-07-2026
7	Bofanglutide linked to meaningful reductions in HbA1c in adults with T2DM	5	7	02-07-2026
8	GLP-1s may lower risk for death, heart events among people with hidradenitis suppurativa	5	7	08-07-2026
9	GLP-1 drugs could become personalized for individuals, study says	0	14.17	01-08-2026

Классификация: . Схожих патентов: 0. Схожих новостей: 9. Тональность: 0. Информативность: 9.88. Источник: jamanetwork.com.